Anxiolytic-like effect of pregabalin on unconditioned fear in the rat: An autoradiographic brain perfusion mapping and functional connectivity study

NeuroImage

Volumn 59, Issue 4, 2012, Pages 4168-4188

  Wang, Zhuo ^a   Pang, Raina D ^a   Hernandez, Martha ^a   Ocampo, Marco A ^a   Holschneider, Daniel P ^a,b,c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c NONE   (United States)

Author keywords

Amygdala; Anxiety; Functional brain mapping; Functional connectivity; Graph theoretical analysis; Insula; Ultrasonic vocalization

Indexed keywords

PREGABALIN;

ADULT ANIMAL; AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN BLOOD FLOW; BRAIN CORTEX; BRAIN MAPPING; BRAIN PERFUSION; BRAIN STEM; CONTROLLED STUDY; FEAR; FUNCTIONAL CONNECTIVITY; HYPOTHALAMUS; IMAGE ANALYSIS; INSULA; MALE; NERVOUS SYSTEM PARAMETERS; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; THALAMUS; TRANQUILIZING ACTIVITY; VOCALIZATION;

ANIMALS; ANTI-ANXIETY AGENTS; AUTORADIOGRAPHY; BRAIN; BRAIN MAPPING; FEAR; GAMMA-AMINOBUTYRIC ACID; MALE; RATS; RATS, WISTAR;

EID: 84857031364     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2011.11.047     Document Type: Article

References (100)

1. Andrews-Hanna J.R., Reidler J.S., Sepulcre J., Poulin R., Buckner R.L. Functional-anatomic fractionation of the brain's default network. Neuron 2010, 65:550-562.
2. Arce E., Miller D.A., Feinstein J.S., Stein M.B., Paulus M.P. Lorazepam dose-dependently decreases risk-taking related activation in limbic areas. Psychopharmacology (Berl) 2006, 189:105-116.
3. Aupperle R.L., Ravindran L., Tankersley D., Flagan T., Stein N.R., Simmons A.N., Stein M.B., Paulus M.P. Pregabalin influences insula and amygdala activation during anticipation of emotional images. Neuropsychopharmacology 2011, 36:1466-1477.
4. Bardin L., Gregoire S., Aliaga M., Malfetes N., Vitton O., Ladure P., Newman-Tancredi A., Depoortere R. Comparison of milnacipran, duloxetine and pregabalin in the formalin pain test and in a model of stress-induced ultrasonic vocalizations in rats. Neurosci. Res. 2010, 66:135-140.
5. Barrett D., Shumake J., Jones D., Gonzalez-Lima F. Metabolic mapping of mouse brain activity after extinction of a conditioned emotional response. J. Neurosci. 2003, 23:5740-5749.
6. Bian F., Li Z., Offord J., Davis M.D., McCormick J., Taylor C.P., Walker L.C. Calcium channel alpha2-delta type 1 subunit is the major binding protein for pregabalin in neocortex, hippocampus, amygdala, and spinal cord: an ex vivo autoradiographic study in alpha2-delta type 1 genetically modified mice. Brain Res. 2006, 1075:68-80.
7. Biswal B., Yetkin F.Z., Haughton V.M., Hyde J.S. Functional connectivity in the motor cortex of resting human brain using echo-planar MRI. Magn. Reson. Med. 1995, 34:537-541.
8. Borsook D., Becerra L., Hargreaves R. A role for fMRI in optimizing CNS drug development. Nat. Rev. Drug Discov. 2006, 5:411-424.
9. Borsook D., Bleakman D., Hargreaves R., Upadhyay J., Schmidt K.F., Becerra L. A 'BOLD' experiment in defining the utility of fMRI in drug development. Neuroimage 2008, 42:461-466.
10. Brandao M.L., Zanoveli J.M., Ruiz-Martinez R.C., Oliveira L.C., Landeira-Fernandez J. Different patterns of freezing behavior organized in the periaqueductal gray of rats: association with different types of anxiety. Behav. Brain Res. 2008, 188:1-13.
11. Brudzynski S.M. Communication of adult rats by ultrasonic vocalization: biological, sociobiological, and neuroscience approaches. ILAR J. 2009, 50:43-50.
12. Buckner R.L., Sepulcre J., Talukdar T., Krienen F.M., Liu H., Hedden T., Andrews-Hanna J.R., Sperling R.A., Johnson K.A. Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer's disease. J. Neurosci. 2009, 29:1860-1873.
13. Bullmore E., Sporns O. Complex brain networks: graph theoretical analysis of structural and functional systems. Nat. Rev. Neurosci. 2009, 10:186-198.
14. Canteras N.S., Resstel L.B., Bertoglio L.J., Carobrez Ade P., Guimaraes F.S. Neuroanatomy of anxiety. Curr. Top. Behav. Neurosci. 2010, 2:77-96.
15. Choi J.S., Brown T.H. Central amygdala lesions block ultrasonic vocalization and freezing as conditional but not unconditional responses. J. Neurosci. 2003, 23:8713-8721.
16. Craig A.D. How do you feel-now? The anterior insula and human awareness. Nat. Rev. Neurosci. 2009, 10:59-70.
17. Critchley H.D., Wiens S., Rotshtein P., Ohman A., Dolan R.J. Neural systems supporting interoceptive awareness. Nat. Neurosci. 2004, 7:189-195.
18. Crofford L.J., Rowbotham M.C., Mease P.J., Russell I.J., Dworkin R.H., Corbin A.E., Young J.P., LaMoreaux L.K., Martin S.A., Sharma U. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2005, 52:1264-1273.
19. Cunningham M.O., Woodhall G.L., Thompson S.E., Dooley D.J., Jones R.S. Dual effects of gabapentin and pregabalin on glutamate release at rat entorhinal synapses in vitro. Eur. J. Neurosci. 2004, 20:1566-1576.
20. Cuomo V., Cagiano R., De Salvia M.A., Maselli M.A., Renna G., Racagni G. Ultrasonic vocalization in response to unavoidable aversive stimuli in rats: effects of benzodiazepines. Life Sci. 1988, 43:485-491.
21. de Nooy W., Mrvar A., Batagelj V. Exploratory social network analysis with Pajek 2005, Cambridge University Press, Cambridge.
22. De Vry J., Benz U., Schreiber R., Traber J. Shock-induced ultrasonic vocalization in young adult rats: a model for testing putative anti-anxiety drugs. Eur. J. Pharmacol. 1993, 249:331-339.
23. Deco G., Jirsa V.K., McIntosh A.R. Emerging concepts for the dynamical organization of resting-state activity in the brain. Nat. Rev. Neurosci. 2011, 12:43-56.
24. Dubois A., Herard A.S., Flandin G., Duchesnay E., Besret L., Frouin V., Hantraye P., Bonvento G., Delzescaux T. Quantitative validation of voxel-wise statistical analyses of autoradiographic rat brain volumes: application to unilateral visual stimulation. Neuroimage 2008, 40:482-494.
25. Dworkin R.H., Corbin A.E., Young J.P., Sharma U., LaMoreaux L., Bockbrader H., Garofalo E.A., Poole R.M. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 2003, 60:1274-1283.
26. Etkin A. Functional neuroanatomy of anxiety: a neural circuit perspective. Curr. Top. Behav. Neurosci. 2010, 2:251-277.
27. Feltner D.E., Crockatt J.G., Dubovsky S.J., Cohn C.K., Shrivastava R.K., Targum S.D., Liu-Dumaw M., Carter C.M., Pande A.C. A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder. J. Clin. Psychopharmacol. 2003, 23:240-249.
28. Feltner D.E., Liu-Dumaw M., Schweizer E., Bielski R. Efficacy of pregabalin in generalized social anxiety disorder: results of a double-blind, placebo-controlled, fixed-dose study. Int. Clin. Psychopharmacol. 2011, 26:213-220.
29. Fidalgo C., Conejo N.M., Gonzalez-Pardo H., Arias J.L. Cortico-limbic-striatal contribution after response and reversal learning: a metabolic mapping study. Brain Res. 2011, 1368:143-150.
30. Field M.J., Cox P.J., Stott E., Melrose H., Offord J., Su T.Z., Bramwell S., Corradini L., England S., Winks J., Kinloch R.A., Hendrich J., Dolphin A.C., Webb T., Williams D. Identification of the alpha2-delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:17537-17542.
31. Field M.J., Oles R.J., Singh L. Pregabalin may represent a novel class of anxiolytic agents with a broad spectrum of activity. Br. J. Pharmacol. 2001, 132:1-4.
32. Fisher R.A. On the 'probable error' of a coefficient of correlation deduced from a small sample. Metron 1921, 1:3-32.
33. French J.A., Kugler A.R., Robbins J.L., Knapp L.E., Garofalo E.A. Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures. Neurology 2003, 60:1631-1637.
34. Friston K.J. Functional and effective connectivity in neuroimaging: a synthesis. Hum. Brain Mapp. 1994, 2:56.
35. Friston K.J., Frith C.D., Liddle P.F., Frackowiak R.S. Comparing functional (PET) images: the assessment of significant change. J. Cereb. Blood Flow Metab. 1991, 11:690-699.
36. Fusar-Poli P., Placentino A., Carletti F., Landi P., Allen P., Surguladze S., Benedetti F., Abbamonte M., Gasparotti R., Barale F., Perez J., McGuire P., Politi P. Functional atlas of emotional faces processing: a voxel-based meta-analysis of 105 functional magnetic resonance imaging studies. J. Psychiatry Neurosci. 2009, 34:418-432.
37. Garner M., Mohler H., Stein D.J., Mueggler T., Baldwin D.S. Research in anxiety disorders: from the bench to the bedside. Eur. Neuropsychopharmacol. 2009, 19:381-390.
38. Gee N.S., Brown J.P., Dissanayake V.U., Offord J., Thurlow R., Woodruff G.N. The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel. J. Biol. Chem. 1996, 271:5768-5776.
39. Goldman H., Sapirstein L.A. Brain blood flow in the conscious and anesthetized rat. Am. J. Physiol. 1973, 224:122-126.
40. Greicius M.D., Krasnow B., Reiss A.L., Menon V. Functional connectivity in the resting brain: a network analysis of the default mode hypothesis. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:253-258.
41. Gsell W., De Sadeleer C., Marchalant Y., MacKenzie E.T., Schumann P., Dauphin F. The use of cerebral blood flow as an index of neuronal activity in functional neuroimaging: experimental and pathophysiological considerations. J. Chem. Neuroanat. 2000, 20:215-224.
42. Hagmann P., Cammoun L., Gigandet X., Meuli R., Honey C.J., Wedeen V.J., Sporns O. Mapping the structural core of human cerebral cortex. PLoS Biol. 2008, 6:e159.
43. Han D.W., Kweon T.D., Lee J.S., Lee Y.W. Antiallodynic effect of pregabalin in rat models of sympathetically maintained and sympathetic independent neuropathic pain. Yonsei Med. J. 2007, 48:41-47.
44. Holschneider D.P., Bradesi S., Mayer E.A. The role of experimental models in developing new treatments for irritable bowel syndrome. Expert Rev. Gastroenterol. Hepatol. 2011, 5:43-57.
45. Holschneider D.P., Maarek J.M. Mapping brain function in freely moving subjects. Neurosci. Biobehav. Rev. 2004, 28:449-461.
46. Holschneider D.P., Maarek J.M. Brain maps on the go: functional imaging during motor challenge in animals. Methods 2008, 45:255-261.
47. Holschneider D.P., Maarek J.M., Harimoto J., Yang J., Scremin O.U. An implantable bolus infusion pump for use in freely moving, nontethered rats. Am. J. Physiol. Heart Circ. Physiol. 2002, 283:H1713-H1719.
48. Horwitz B., McIntosh A.R., Haxby J.V., Grady C.L. Network analysis of brain cognitive function using metabolic and blood flow data. Behav. Brain Res. 1995, 66:187-193.
49. Jones S.C., Korfali E., Marshall S.A. Cerebral blood flow with the indicator fractionation of [14C]iodoantipyrine: effect of PaCO2 on cerebral venous appearance time. J. Cereb. Blood Flow Metab. 1991, 11:236-241.
50. Jurgens U. Neural pathways underlying vocal control. Neurosci. Biobehav. Rev. 2002, 26:235-258.
51. Kamada T., Kawai S. An algorithm for drawing general undirected graphs. Inf. Process. Lett. 1988, 31:7-15.
52. Keri S., Gulyas B. Four facets of a single brain: behaviour, cerebral blood flow/metabolism, neuronal activity and neurotransmitter dynamics. Neuroreport 2003, 14:1097-1106.
53. Lee J.S., Ahn S.H., Lee D.S., Oh S.H., Kim C.S., Jeong J.M., Park K.S., Chung J.K., Lee M.C. Voxel-based statistical analysis of cerebral glucose metabolism in the rat cortical deafness model by 3D reconstruction of brain from autoradiographic images. Eur. J. Nucl. Med. Mol. Imaging 2005, 32:696-701.
54. Li Z., Taylor C.P., Weber M., Piechan J., Prior F., Bian F., Cui M., Hoffman D., Donevan S. Pregabalin is a potent and selective ligand for [alpha]2[delta]-1 and [alpha]2[delta]-2 calcium channel subunits. Eur. J. Pharmacol. 2011, 667:80-90.
55. Liang Z., King J., Zhang N. Uncovering intrinsic connectional architecture of functional networks in awake rat brain. J. Neurosci. 2011, 31:3776-3783.
56. Liang Z., King J., Zhang N. Anticorrelated resting-state functional connectivity in awake rat brain. Neuroimage 2012, 59:1190-1199.
57. Magnuson M., Majeed W., Keilholz S.D. Functional connectivity in blood oxygenation level-dependent and cerebral blood volume-weighted resting state functional magnetic resonance imaging in the rat brain. J. Magn. Reson. Imaging 2010, 32:584-592.
58. Micheva K.D., Taylor C.P., Smith S.J. Pregabalin reduces the release of synaptic vesicles from cultured hippocampal neurons. Mol. Pharmacol. 2006, 70:467-476.
59. Mintun M.A., Lundstrom B.N., Snyder A.Z., Vlassenko A.G., Shulman G.L., Raichle M.E. Blood flow and oxygen delivery to human brain during functional activity: theoretical modeling and experimental data. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:6859-6864.
60. Morcom A.M., Fletcher P.C. Does the brain have a baseline? Why we should be resisting a rest. Neuroimage 2007, 37:1073-1082.
61. Nair H.P., Gonzalez-Lima F. Extinction of behavior in infant rats: development of functional coupling between septal, hippocampal, and ventral tegmental regions. J. Neurosci. 1999, 19:8646-8655.
62. Nguyen P.T., Holschneider D.P., Maarek J.M., Yang J., Mandelkern M.A. Statistical parametric mapping applied to an autoradiographic study of cerebral activation during treadmill walking in rats. Neuroimage 2004, 23:252-259.
63. Nicolas L.B., Klein S., Prinssen E.P. Defensive-like behaviors induced by ultrasound: further pharmacological characterization in Lister-hooded rats. Psychopharmacology (Berl) 2007, 194:243-252.
64. Padilla E., Shumake J., Barrett D.W., Sheridan E.C., Gonzalez-Lima F. Mesolimbic effects of the antidepressant fluoxetine in Holtzman rats, a genetic strain with increased vulnerability to stress. Brain Res. 2011, 1387:71-84.
65. Pande A.C., Feltner D.E., Jefferson J.W., Davidson J.R., Pollack M., Stein M.B., Lydiard R.B., Futterer R., Robinson P., Slomkowski M., DuBoff E., Phelps M., Janney C.A., Werth J.L. Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: a placebo-controlled, multicenter study. J. Clin. Psychopharmacol. 2004, 24:141-149.
66. Patlak C.S., Blasberg R.G., Fenstermacher J.D. An evaluation of errors in the determination of blood flow by the indicator fractionation and tissue equilibration (Kety) methods. J. Cereb. Blood Flow Metab. 1984, 4:47-60.
67. Paulus M.P., Feinstein J.S., Castillo G., Simmons A.N., Stein M.B. Dose-dependent decrease of activation in bilateral amygdala and insula by lorazepam during emotion processing. Arch. Gen. Psychiatry 2005, 62:282-288.
68. Paulus M.P., Stein M.B. An insular view of anxiety. Biol. Psychiatry 2006, 60:383-387.
69. Pawela C.P., Biswal B.B., Cho Y.R., Kao D.S., Li R., Jones S.R., Schulte M.L., Matloub H.S., Hudetz A.G., Hyde J.S. Resting-state functional connectivity of the rat brain. Magn. Reson. Med. 2008, 59:1021-1029.
70. Pawela C.P., Biswal B.B., Hudetz A.G., Li R., Jones S.R., Cho Y.R., Matloub H.S., Hyde J.S. Interhemispheric neuroplasticity following limb deafferentation detected by resting-state functional connectivity magnetic resonance imaging (fcMRI) and functional magnetic resonance imaging (fMRI). Neuroimage 2010, 49:2467-2478.
71. Paxinos G., Watson C. The rat brain in stereotatic coordinates 2007, Elsevier Academic Press, New York. 6th ed.
72. Price M.T., Fibiger H.C. Discriminated escape learning and response to electric shock after 6-hydroxydopamine lesions of the nigro-neostriatal dopaminergic projection. Pharmacol. Biochem. Behav. 1975, 3:285-290.
73. Raichle M.E., MacLeod A.M., Snyder A.Z., Powers W.J., Gusnard D.A., Shulman G.L. A default mode of brain function. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:676-682.
74. Raichle M.E., Snyder A.Z. A default mode of brain function: a brief history of an evolving idea. Neuroimage 2007, 37:1083-1090. (discussion 1097-1089).
75. Riha P.D., Rojas J.C., Gonzalez-Lima F. Beneficial network effects of methylene blue in an amnestic model. Neuroimage 2011, 54:2623-2634.
76. Rojas J.C., Simola N., Kermath B.A., Kane J.R., Schallert T., Gonzalez-Lima F. Striatal neuroprotection with methylene blue. Neuroscience 2009, 163:877-889.
77. Rosen J.B., Donley M.P. Animal studies of amygdala function in fear and uncertainty: relevance to human research. Biol. Psychol. 2006, 73:49-60.
78. Rosen J.B., Pagani J.H., Rolla K.L., Davis C. Analysis of behavioral constraints and the neuroanatomy of fear to the predator odor trimethylthiazoline: a model for animal phobias. Neurosci. Biobehav. Rev. 2008, 32:1267-1276.
79. Rosenstock J., Tuchman M., LaMoreaux L., Sharma U. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain 2004, 110:628-638.
80. Sabatinelli D., Fortune E.E., Li Q., Siddiqui A., Krafft C., Oliver W.T., Beck S., Jeffries J. Emotional perception: meta-analyses of face and natural scene processing. Neuroimage 2011, 54:2524-2533.
81. Sadler T.R., Nguyen P.T., Yang J., Givrad T.K., Mayer E.A., Maarek J.M., Hinton D.R., Holschneider D.P. Antenatal maternal stress alters functional brain responses in adult offspring during conditioned fear. Brain Res. 2011, 1385:163-174.
82. Sakurada O., Kennedy C., Jehle J., Brown J.D., Carbin G.L., Sokoloff L. Measurement of local cerebral blood flow with iodo [14C] antipyrine. Am. J. Physiol. 1978, 234:H59-H66.
83. Sanchez C. Stress-induced vocalisation in adult animals. A valid model of anxiety?. Eur. J. Pharmacol. 2003, 463:133-143.
84. Schwarz A.J., Gozzi A., Bifone A. Community structure and modularity in networks of correlated brain activity. Magn. Reson. Imaging 2008, 26:914-920.
85. Schwarz A.J., Gozzi A., Bifone A. Community structure in networks of functional connectivity: resolving functional organization in the rat brain with pharmacological MRI. Neuroimage 2009, 47:302-311.
86. Schwarz A.J., Gozzi A., Reese T., Bifone A. Functional connectivity in the pharmacologically activated brain: resolving networks of correlated responses to d-amphetamine. Magn. Reson. Med. 2007, 57:704-713.
87. Schwarz A.J., Gozzi A., Reese T., Heidbreder C.A., Bifone A. Pharmacological modulation of functional connectivity: the correlation structure underlying the phMRI response to d-amphetamine modified by selective dopamine D3 receptor antagonist SB277011A. Magn. Reson. Imaging 2007, 25:811-820.
88. Sehlmeyer C., Schoning S., Zwitserlood P., Pfleiderer B., Kircher T., Arolt V., Konrad C. Human fear conditioning and extinction in neuroimaging: a systematic review. PLoS One 2009, 4:e5865.
89. Shumake J., Conejo-Jimenez N., Gonzalez-Pardo H., Gonzalez-Lima F. Brain differences in newborn rats predisposed to helpless and depressive behavior. Brain Res. 2004, 1030:267-276.
90. Soncrant T.T., Horwitz B., Holloway H.W., Rapoport S.I. The pattern of functional coupling of brain regions in the awake rat. Brain Res. 1986, 369:1-11.
91. Stein D.J., Baldwin D.S., Baldinetti F., Mandel F. Efficacy of pregabalin in depressive symptoms associated with generalized anxiety disorder: a pooled analysis of 6 studies. Eur. Neuropsychopharmacol. 2008, 18:422-430.
92. Taylor C.P. Mechanisms of analgesia by gabapentin and pregabalin-calcium channel alpha2-delta [Cavalpha2-delta] ligands. Pain 2009, 142:13-16.
93. Taylor C.P., Garrido R. Immunostaining of rat brain, spinal cord, sensory neurons and skeletal muscle for calcium channel alpha2-delta (alpha2-delta) type 1 protein. Neuroscience 2008, 155:510-521.
94. Tillisch K., Wang Z., Kilpatrick L., Holschneider D.P., Mayer E.A. Studying the brain-gut axis with pharmacological imaging. Ann. N. Y. Acad. Sci. 2008, 1144:256-264.
95. Van Uitert R.L., Levy D.E. Regional brain blood flow in the conscious gerbil. Stroke 1978, 9:67-72.
96. Vartanian M.G., Radulovic L.L., Kinsora J.J., Serpa K.A., Vergnes M., Bertram E., Taylor C.P. Activity profile of pregabalin in rodent models of epilepsy and ataxia. Epilepsy Res. 2006, 68:189-205.
97. Vogt B.A., Vogt L., Farber N.B. Cingulate cortex and disease models. The rat nervous system 2004, 705-727. Academic Press, San Diego. G. Paxinos (Ed.).
98. Wang Z., Bradesi S., Charles J.R., Pang R.D., Maarek J.M., Mayer E.A., Holschneider D.P. Functional brain activation during retrieval of visceral pain-conditioned passive avoidance in the rat. Pain 2011, 152:2746-2756.
99. Wohr M., Borta A., Schwarting R.K. Overt behavior and ultrasonic vocalization in a fear conditioning paradigm: a dose-response study in the rat. Neurobiol. Learn. Mem. 2005, 84:228-240.
100. Zohar J., Matar M.A., Ifergane G., Kaplan Z., Cohen H. Brief post-stressor treatment with pregabalin in an animal model for PTSD: short-term anxiolytic effects without long-term anxiogenic effect. Eur. Neuropsychopharmacol. 2008, 18:653-666.